Friday, July 31, 2026

Xenovax PCM4: The Next-Gen Vaccine Transforming Pig Farming in Asia – Find Out How!

CARESIDE's swine vaccine technology certified as New Excellent Technology, enhancing protection and reducing farmer labor demands.

North Korea’s Ri Se Ung Clinches Bronze in Thrilling Wrestling Match at Paris Olympics

Competing in the men's Greco-Roman 60kg category at the Paris Olympics, North Korea's Ri Se Ung earned a bronze medal.

Kia’s EV3 Triumphs Again—How Hyundai and Kia Are Redefining the Global Auto Game

Hyundai Motor Group celebrates Kia's EV3 win at the World Car Awards, marking its second consecutive title and highlighting innovation.

Tag: Onconic Therapeutics

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Onconic Therapeutics Licenses GERD Drug Zaqubo to Indonesia’s Dexa Medica

Onconic Therapeutics partners with Dexa Medica to commercialize GERD treatment Zaqubo in Indonesia, enhancing its global expansion strategy.

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

Your Guide to Jaqbo: The New GERD Treatment Shaping the Future of Chronic Care

Onconic Therapeutics begins a Phase 3 trial for Jaqbo, aiming to expand GERD treatment options and enhance long-term management strategies.

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.